Table 3.
Outcome and clinical parameters during ICU stay.
| Parameter | (1) Whole Cohort |
(2) Survivor |
(3) Non-Survivor |
p-Value (2) vs. (3) |
|---|---|---|---|---|
| Hospital Survival | 71 (25.9%) | 71 (100%) | 0 (0%) | <0.0001 |
| Lenght of ICU Stay [days] | 9.0 ± 13.9 | 19.8 ± 16.5 | 5.2 ± 10.6 | <0.0001 |
| TTM 33 °C | 208 (75.9%) | 46 (64.8%) | 152 (74.9%) | 0.7531 |
| NSE-Day 1 | 96.1 ± 101.4 | 68.6 ± 48.3 | 109.3 ± 115.6 | 0.0158 |
| NSE-Day 2 | 116.5 ± 98.7 | 74.5 ± 47.7 | 147.3 ± 114.2 | <0.0001 |
| NSE-Day 3 | 136.9 ± 150.2 | 73.9 ± 76.2 | 184.5 ± 1773.8 | 0.0005 |
| Respiratory Support [h] | 124.7 ± 140.9 | 228.4 ± 177.7 | 88.5 ± 104.0 | <0.0001 |
| Renal Replacement Therapy | 59 (21.3%) | 14 (19.7%) | 45 (22.2%) | 0.6565 |
Data given in mean ± standard deviation or number of patients (percentage). p-values are calculated between survivors and non-survivors. (significance level p-value < 0.05). Abbreviations: NSE—Neuron Specific Enolase.